Revtorpyk was approved for women with advanced breast cancer whose disease worsened after previous hormone-based treatments; patients receiving the three-drug combination went a median 9.3 months without progression, compared with two months on standard therapy alone | Read More in ynet – Culture
Death toll in Bangkok pub fire rises to 32 with dozens still in hospital, officials saySara Netanyahu requests Shin Bet security for her family, regardless of election outcome – reportSara Netanyahu requests Shin Bet security for her family, regardless of election outcome – report
One dead, two missing after boat with 19 aboard capsizes in San Francisco Bay, near AlcatrazIsraeli man dies three months after Iranian missile strike on Haifa
Another grenade hits Sushi restaurant chain as police warn of nationwide retaliation
Botox, suits and Israel: Ahmadinejad’s transformation and alleged Mossad courtship
Trump warns of total destruction as Hormuz stays open but Iran faces blockade
Women of the Wall clash with worshippers at Western Wall
Haifa man dies of Iranian missile strike injuries
Grenade hits another Japanika branch
Amb. Huckabee: ‘Ro Khanna – come see the full picture, we’ll leave a light on’Death toll in Bangkok pub fire rises to 32 with dozens still in hospital, officials saySara Netanyahu requests Shin Bet security for her family, regardless of election outcome – reportSara Netanyahu requests Shin Bet security for her family, regardless of election outcome – reportIsraeli man dies three months after Iranian missile strike on Haifa